Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A)
Clinical trial NCT06385483 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06385483
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2022-12-06
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.